Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging

Circulation Journal

Volumn 72, Issue 3, 2008, Pages 378-383

  Motoyasu, Munenobu ^a   Kurita, Tairo ^a   Onishi, Katsuya ^a   Uemura, Shoko ^a   Tanigawa, Takashi ^a   Okinaka, Tsutomu ^a   Takeda, Kan ^a   Nakano, Takeshi ^a   Ito, Masaaki ^a   Sakuma, Hajime ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diastolic function; Hypertrophic cardiomyopathy; Late gadolinium enhancement; Magnetic resonance imaging

Indexed keywords

GADOLINIUM;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIASTOLE; DIASTOLIC DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; SCORING SYSTEM; STATISTICAL SIGNIFICANCE;

AGED; BLOOD PRESSURE; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; FIBROSIS; GADOLINIUM; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 42649115129     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.72.378     Document Type: Article

References (31)

1. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350: 127-133.
2. Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
3. Kitaoka H, Kubo T, Okawa M, Hitomi N, Furuno T, Doi YL. Left ventricular remodeling of hypertrophic cardiomyopathy: Longitudinal observation in a rural community. Circ J 2006; 70: 1543-1549.
4. Braunwald E, Seidman CE, Sigwart U. Contemporary evaluation and management of hypertrophic cardiomyopathy. Circulation 2002; 106: 1312-1316.
5. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: Clinical spectrum and treatment. Circulation 1995; 92: 1680-1692.
6. Efthimiadis GK Giannakoulas G, Parcharidou DG, Karvounis HI, Mochlas ST, Styliadis IH, et al. Clinical significance of tissue Doppler imaging in patients with hypertrophic cardiomyopathy. Circ J 2007; 71: 897-903.
7. Nishimura RA, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR Jr, Tajik AJ. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: A simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996; 28: 1226-1233.
8. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15; 808-813.
9. Briguori C, Betocchi S, Romano M, Manganelli F, Angela Losi M, Ciampi Q, et al. Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol 1999; 84: 309-315.
10. Hoffmann U, Globits S, Stefenelli T, Loewe C, Kostner K, Frank H. The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: A cine MRI study. J Magn Reson Imaging 2001; 14: 16-22.
11. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, Maron BJ. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005; 112: 855-861.
12. Maron BJ, Epstein SE, Roberts WC. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979; 43: 1086-1102.
13. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986; 8: 545-557.
14. Unverferth DV, Baker BB, Pearce LI, Lautman I, Roberts WC. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol 1987; 59: 932-936.
15. Kim RJ, Fieno DS, Parrish TB, Parrish TB, Harris K, Chen EL, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
16. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-28.
17. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001; 103: 2780-2783.
18. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Pennell DJ. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 43: 2260-2264.
19. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliot MK, Klocke FJ, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40: 2156-2164.
20. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281: 650-655.
21. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 1778-1785.
22. Vasan RS, Levy D. Defining diastolic heart failure: A call for standardized diagnostic criteria. Circulation 2000; 101: 2118-2121.
23. Moon JCC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003; 41: 1561-1567.
24. Waller TA, Hiser WL, Capehart JE, Roberts WC. Comparison of clinical and morphological cardiac findings in patients having cardiac transplantation for ischemic cardiomyopathy, idiopathic dilated cardiomyopathy, and dilated hypertrophic cardiomyopathy. Am J Cardiol 1998; 81: 884-894.
25. Yamano T, Nakamura T, Sakamoto K, Hikosaka T, Zen K, Nakamura T, et al. Assessment of left ventricular diastolic function by gated single-photon emission tomography: Comparison with Doppler echocardiography. Eur J Nucl Med Mol Imaging 2003; 11: 1532-1537.
26. Miller S, Simonetti OP, Carr J, Kramer U, Finn JP. MR imaging of the heart with cine true fast imaging with steady-state precession: Influence of spatial and temporal resolutions on left ventricular functional parameters. Radiology 2002; 223: 263-269.
27. Yetman AT, Gow RM, Seib P, Morrow WR, McCrindle BW. Exercise capacity in children with hypertrophic cardiomyopathy and its relation to diastolic left ventricular function. Am J Cardiol 2001; 87: 491-493.
28. Shirani J, Pick R, Roberts WC, Maron BJ. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol 2000; 35: 36-44.
29. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: Clinical follow-up and diagnostic correlates. J Am Coll Cardiol 1990; 15: 83-90.
30. Aroesty JM, McKay RG, Heller GV, Royal HD, Als AV, Grossman W. Simultaneous assessment of left ventricular systolic and diastolic dysfunction during pacing-induced ischemia. Circulation 1985; 71: 889-900.
31. Shirani J, Maron BJ, Cannon RO III, Shahin S, Robert WC. Clinico-pathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation. Am J Cardiol 1993; 72: 434-440.